Mireille N. Porter

University Of Cape Town
Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Cutaneous and histopathological features of drug reaction with eosinophila and systemic symptoms differ by HIV status in an HIV-endemic setting.

Cutaneous and histopathological features of drug reaction with eosinophila and systemic symptoms differ by HIV status in an HIV-endemic setting.

Journal: JAAD international
Published: May 07, 2026

Prospective longitudinal study of psychological sequelae, self-perception of body image, and quality of life in severe cutaneous adverse drug reactions: a case-control study.

Prospective longitudinal study of psychological sequelae, self-perception of body image, and quality of life in severe cutaneous adverse drug reactions: a case-control study.

Journal: Frontiers in medicine
Published: December 23, 2025

Presumed Levofloxacin-associated Lichenoid Drug Eruption in a Child With Rifampicin-resistant Tuberculosis.

Presumed Levofloxacin-associated Lichenoid Drug Eruption in a Child With Rifampicin-resistant Tuberculosis.

Journal: The Pediatric infectious disease journal
Published: March 10, 2025

Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis Settings.

Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis Settings.

Journal: The journal of allergy and clinical immunology. In practice
Published: September 18, 2024

Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting.

Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting.

Journal: Frontiers in allergy
Published: August 15, 2024

First-Line Antituberculosis Drug Challenge Reactions in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in an HIV Endemic Setting.

First-Line Antituberculosis Drug Challenge Reactions in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in an HIV Endemic Setting.

Journal: The journal of allergy and clinical immunology. In practice
Published: February 05, 2024

Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting.

Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: July 26, 2023

Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative study.

Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative study.

Journal: The journal of allergy and clinical immunology. Global
Published: July 16, 2023

Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions.

Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: May 22, 2023

Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients.

Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients.

Journal: Frontiers in medicine
Published: December 07, 2022

IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.

IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.

Journal: The Journal of investigative dermatology
Published: January 24, 2022

Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV.

Pattern and impact of drug-induced liver injury in South African patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and a high burden of HIV.

Journal: The journal of allergy and clinical immunology. In practice
Published: January 20, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026